These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3377859)

  • 1. Early DNA damage induced in cells exposed to N10-propargyl 5,8-dideazafolic acid (CB 3717) or methotrexate.
    Lorico A; Toffoli G; Boiocchi M; Erba E; Broggini M; Rappa G; D'Incalci M
    Biochem Pharmacol; 1988 May; 37(9):1875-6. PubMed ID: 3377859
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinazoline antifolates inhibiting thymidylate synthase: synthesis of gamma-linked peptide and amide analogues of 2-desamino-2-methyl-N10-propargyl- 5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Thornton TJ; Pawelczak K; Boyle FT; Bisset GM
    Adv Exp Med Biol; 1993; 338():593-6. PubMed ID: 8304188
    [No Abstract]   [Full Text] [Related]  

  • 3. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid.
    Lorico A; Toffoli G; Boiocchi M; Erba E; Broggini M; Rappa G; D'Incalci M
    Cancer Res; 1988 Apr; 48(8):2036-41. PubMed ID: 3349474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The duration of the inhibition of thymidylate synthase in intact L1210 cells exposed to two different classes of quinazoline analogues.
    Kimbell R; Jackman AL; Boyle FT; Hardcastle A; Aherne W
    Adv Exp Med Biol; 1993; 338():597-600. PubMed ID: 8304189
    [No Abstract]   [Full Text] [Related]  

  • 8. The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Jackman AL; Newell DR; Gibson W; Jodrell DI; Taylor GA; Bishop JA; Hughes LR; Calvert AH
    Biochem Pharmacol; 1991 Oct; 42(10):1885-95. PubMed ID: 1741766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole.
    Curtin NJ; Harris AL; Aherne GW
    Cancer Res; 1991 May; 51(9):2346-52. PubMed ID: 2015598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductase.
    Cheng YC; Dutschman GE; Starnes MC; Fisher MH; Nanavathi NT; Nair MG
    Cancer Res; 1985 Feb; 45(2):598-600. PubMed ID: 3917852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted-2-desamino-2-methyl-quinazolinones. A series of novel antitumour agents.
    Boyle FT; Matusiak ZS; Hughes LR; Slater AM; Stephens TC; Smith MN; Brown M; Kimbell R; Jackman AL
    Adv Exp Med Biol; 1993; 338():585-8. PubMed ID: 8304185
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717).
    Calvert AH; Newell DR; Jackman AL; Gumbrell LA; Sikora E; Grzelakowska-Sztabert B; Bishop JA; Judson IR; Harland SJ; Harrap KR
    NCI Monogr; 1987; (5):213-8. PubMed ID: 3431591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ornithine decarboxylase induction in mouse kidney as indicator of renal damage. Differential nephrotoxic effect of anticancer antifolate drugs.
    Manteuffel-Cymborowska M; Chmurzyńska W; Grzelakowska-Sztabert B
    Cancer Lett; 1991 Sep; 59(3):237-41. PubMed ID: 1913620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate analogues. 35. Synthesis and biological evaluation of 1-deaza, 3-deaza, and bridge-elongated analogues of N10-propargyl-5,8-dideazafolic acid.
    Li SW; Nair MG; Edwards DM; Kisliuk RL; Gaumont Y; Dev IK; Duch DS; Humphreys J; Smith GK; Ferone R
    J Med Chem; 1991 Sep; 34(9):2746-54. PubMed ID: 1895294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
    Cantwell BM; Harris AL
    Br J Cancer; 1988 Aug; 58(2):189-90. PubMed ID: 3166908
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance.
    Calvert AH; Jones TR; Dady PJ; Grzelakowska-Sztabert B; Paine RM; Taylor GA; Harrap KR
    Eur J Cancer (1965); 1980 May; 16(5):713-22. PubMed ID: 7389797
    [No Abstract]   [Full Text] [Related]  

  • 20. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.